Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A complex role of herpes viruses in the disease process of multiple sclerosis.
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Does interferon Beta-1a impact pure-tone hearing sensitivity among individuals with multiple sclerosis?
FTY720 in patients with primary progressive multiple sclerosis (INFORMS)
Gait variability measures reveal differences between multiple sclerosis patients and healthy controls.
Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.
Safety issue puts daclizumab in doubt for MS
Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial.
White matter astrocytes in health and disease.
A high-density screen for linkage in multiple sclerosis.
Sanofi withdraws Campath in US and EU
Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.
Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
The Stigma Scale for Chronic Illnesses 8-Item Version (SSCI-8): Development, Validation and Use Across Neurological Conditions.
Glatiramer acetate does not protect from acute ischemic stroke in mice.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α
Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies.
Prevention and treatment of MS: studying the effects of vitamin D.
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Potassium-Retaining Diuretics: Amiloride

Pages